Coronavirus: US, partners donate €600 million to support vaccine manufacturing in South Africa
Health
THE U.S. International Development Finance Corporation (DFC) on Wednesday announced a joint financing package of 600 million euros for Aspen Pharmacare Holdings Ltd. to expand local vaccine manufacturing capacity. A statement by the U.S. State Department Spokesperson, Ned Price, said DFC is working together with DEG of Germany, Proparco of France and the International Finance Corporation (IFC), an affiliate of the World Bank, to provide financing support.
It said the package would help increase capacity to support Aspen’s efforts to produce COVID-19 vaccines with Stringent Regulatory Authorization (SRA) and/or World Health Organization (WHO) Emergency Use Listing, including the Johnson & Johnson COVID-19 vaccine.
The vaccines will be primarily distributed to the African Union, South African Government and COVAX, the statement said.
It added that the effort supports the US Administration’s goal “to scale vaccine production, invest in African ingenuity and resilience, and help the global community beat this COVID-19 pandemic”.
Aspen Pharmacare Holdings Ltd. has its headquarters in South Africa.
NAN
– July 01, 2021 @ 09:10 GMT|
Related Posts
Cancer society calls for higher funding for treatment in 2025 budget
THE President of the Nigerian Cancer Society (NCS), Prof. Abidemi Omonisi, has called for a significant increase in the allocation...
Read MoreKogi State Govt. to spend over 7BN to revamp additional 88 PHCs
KOGI state government is to spend over 7 Billion Naira to revamp additional 88 Primary Healthcare Centres across the 21...
Read MoreHospitals in Akwa Ibom indulge in organ harvesting; 750,000 children trafficked – NAPTIP
NATIONAL Agency for Prohibition of Trafficking in Persons, NAPTIP has accused some medical centres and personnel of indulging in organ...
Read MoreMost Read
Subscribe to Our Newsletter
Keep abreast of news and other developments from our website.